News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
Content Sharing
<Results> Clover Biopharmaceuticals (02197.HK) Narrows Annual Loss to RMB205 Million
Clover Biopharmaceuticals-B (02197.HK) announced its annual results for the year ended last December. The revenue was RMB3.505 million, representing a year-on-year decrease of 90.9...
Reset
Send
The window will close in 5 seconds
<Results> Clover Biopharmaceuticals (02197.HK) Narrows Annual Loss to RMB205 Million
Close
Recommend
9
Positive
6
Negative
7
 
 

Clover Biopharmaceuticals-B (02197.HK)  0.000 (0.000%)   announced its annual results for the year ended last December. The revenue was RMB3.505 million, representing a year-on-year decrease of 90.9%. The loss narrowed to RMB205 million, compared to a loss of RMB903 million in the same period last year; the loss per share was RMB0.16. No dividend was declared.

Dividend History
Announce DateEventParticular
2025/08/27InterimNo Dividend
2025/03/31FinalNo Dividend
2024/08/28InterimNo Dividend
2024/03/27FinalNo Dividend

Under non-IFRS standards, the adjusted loss narrowed from RMB887 million in the previous year to RMB198 million. (ca/da)(HK stocks quote is delayed for at least 15 mins.)



This article was automatically translated by AI, the Chinese version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation.

Auto-translated by AI

AASTOCKS Financial News

Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.